Review article · 2026 · Open access
Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease
Research, 9, 1239 · Published 1 January 2026 · DOI 10.34133/research.1239
In brief
“Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease” is a 2026 review article by Wenxia Shao and 3 co-authors, published in Research. OpenAlex counts 1 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Research.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 0.69
- References
- 87
- Authors
- 4
Abstract
Chimeric antigen receptor T (CAR-T) cell therapy, a groundbreaking technology in tumor immunotherapy, has demonstrated unprecedented potential in the field of autoimmune diseases in recent years. This article provides a systematic review of the developmental trajectory and core concepts of CAR-T-cell therapy in autoimmune diseases, emphasizing its conceptual evolution from traditional "killing" strategies to "precision immune remodeling". Leveraging multitarget approaches (e.g., CD19 and B-cell maturation antigen) and chimeric autoantigen receptor technology, it achieves efficient elimination of pathogenic B cells, plasma cells, and autoreactive T cells, along with profound remodeling of the immune microenvironment, thereby inducing long-term disease remission and restoring immune tolerance. Nevertheless, unresolved challenges still exist in monotherapy strategies, such as antigen escape, nontumor toxicity of emerging targets, limited in vivo persistence, high production costs, and immune reconstitution imbalance. Future research ought to concentrate on the development of multitarget/logic-gated chimeric antigen receptor constructs, the optimization of chimeric antigen receptor architecture and nonviral delivery systems, the validation of the long-term safety of universal CAR-T cells, the customization of personalized treatment regimens, and the exploration of mechanisms for modulating the immune microenvironment. This review emphasizes that CAR-T-cell therapy shows potential for initiating a new era of personalized, mechanism-driven treatment for autoimmune diseases, offering crucial insights for clinical translation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Shao, W., Liu, J., Sun, M., & Yu, D. (2026). Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease. Research, 9, 1239. https://doi.org/10.34133/research.1239
MLA 9
Shao, Wenxia, et al. “Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease.” Research, vol. 9, 2026, p. 1239. https://doi.org/10.34133/research.1239.
Chicago
Shao, Wenxia, J Liu, Ming Sun, and Daojun Yu. 2026. “Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease.” Research 9: 1239. https://doi.org/10.34133/research.1239.
Harvard
Shao, W. et al. (2026) ‘Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease’, Research, 9, p. 1239. doi:10.34133/research.1239.
IEEE
W. Shao, J. Liu, M. Sun, and D. Yu, “Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease,” Research, vol. 9, p. 1239, 2026, doi: 10.34133/research.1239.
BibTeX
@article{shao2026chimeric,
title = {{Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease}},
author = {Shao, Wenxia and Liu, J and Sun, Ming and Yu, Daojun},
journal = {Research},
year = {2026},
volume = {9},
pages = {1239},
doi = {10.34133/research.1239},
url = {https://doi.org/10.34133/research.1239}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- CAR T-cell therapy
- autoimmune disease
- chimeric antigen receptor
- immune remodeling
- B-cell depletion
- CD19
- BCMA
- antigen escape
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Shao, W., Liu, J., Sun, M., & Yu, D. (2026). Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease. Research, 9, 1239. https://doi.org/10.34133/research.1239
How many times has this paper been cited?
1 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Research: sign in and open the full text from this page.
Who wrote this paper?
Wenxia Shao, J Liu, Ming Sun, Daojun Yu.
What is the DOI of this paper?
10.34133/research.1239, permanently at https://doi.org/10.34133/research.1239. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.